← Human Trials & Peer-Reviewed Studies
Advantages of Recombinant Follicle-Stimulating Hormone over Human Menopausal Gonadotropin in Intrauterine Insemination: A Randomized Clinical Trial in Polycystic Ovary Syndrome-Associated Infertility
Plain-language guide to PMID 26228499 (2016): randomized controlled trial study of HMG (Human Menopausal Gonadotropin).
Key Facts
- PMID
- 26228499
- Journal
- Gynecologic and obstetric investigation
- Year
- 2016
- Study type
- Randomized Controlled Trial
- Authors
- Rashidi M et al. (3 authors)
- DOI
- 10.1159/000435773
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at HMG (Human Menopausal Gonadotropin).
The purpose of the current study was to compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (rFSH) combined with clomiphene citrate (CC) in IUI cycles for polycystic ovary syndrome-associated infertility.
Why It Was Studied
Various gonadotropin preparations have been used for ovarian stimulation in intrauterine insemination (IUI).
Who Took Part
PubMed indexes the participants as adults, both men and women.
How the Study Was Run
The design is described as randomized.
The participants were allocated by chance, so the HMG (Human Menopausal Gonadotropin) group and the comparison group should start out alike.
In this prospective trial, couples prepared for IUI cycles were randomly allocated either to receive CC and rFSH (group A, n = 132) or CC and hMG (group B, n = 144) for ovarian stimulation.
Outcomes including rates of clinical pregnancy, miscarriage, ovarian hyperstimulation syndrome, multiple pregnancy, cancellation and live birth were compared.
What Was Measured
Topics PubMed links to this paper include Polycystic Ovary Syndrome, Menotropins, Recombinant Proteins, Clomiphene, Infertility, Female, Ovulation Induction and Follicle Stimulating Hormone.
The authors tagged it with the keywords Anovulation, Human menopausal gonadotropin, Intrauterine insemination and Recombinant follicle-stimulating hormone.
What This Means in Plain Language
The paper is a randomized study of HMG (Human Menopausal Gonadotropin).
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2016 (Gynecologic and obstetric investigation), a journal based in Switzerland.
More context: the HMG (Human Menopausal Gonadotropin) compound page, all human trials.
Our Notes on the Compound
HMG (Human Menopausal Gonadotropin): Menotropins: a glycoprotein preparation that supplies follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.